Home  >  Products  >  MYOT (myotilin ) Blocking Peptide (the C terminal of MYOT)(100ug)
MYOT (myotilin ) Blocking Peptide (the C terminal of MYOT)(100ug)

MYOT (myotilin ) Blocking Peptide (the C terminal of MYOT)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MYOT Antibody (ARP64117_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP64117
Size: 100ug
Weight: 55kDa
Gene: 9499
Format: Lyophilized powder
Target: This gene encodes a cystoskeletal protein which plays a significant role in the stability of thin filaments during muscle contraction. This protein binds F-actin, crosslinks actin filaments, and prevents latrunculin A-induced filament disassembly. Mutations in this gene have been associated with limb-girdle muscular dystrophy and myofibrillar myopathies. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined.
Alternative names: LGMD1; LGMD1A; TTID